What is HC Wainwright’s Estimate for PTGX Q1 Earnings?
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Investment analysts at HC Wainwright lifted their Q1 2025 earnings per share estimates for Protagonist Therapeutics in a report released on Monday, February 24th. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($0.57) per share for the quarter, up from their prior estimate […]
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Investment analysts at HC Wainwright lifted their Q1 2025 earnings per share estimates for Protagonist Therapeutics in a report released on Monday, February 24th. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($0.57) per share for the quarter, up from their prior estimate […]
